These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2448686)

  • 1. Development of an optimum dosage regimen for pentobarbital in patients with severe head injury.
    Nishihara K; Kohda Y; Tsutsumi H; Sasaki M; Aruga T; Toyooka H; Mii K
    Neurol Med Chir (Tokyo); 1987 Jul; 27(7):617-22. PubMed ID: 2448686
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of high-dose pentobarbital in severe head trauma.
    Bayliff CD; Schwartz ML; Hardy BG
    Clin Pharmacol Ther; 1985 Oct; 38(4):457-61. PubMed ID: 4042529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of antemortem medication on the determination of brain death.
    Saito T; Takeichi S; Nakajima Y; Yukawa N; Osawa M
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):484-7. PubMed ID: 8583693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of head injury coma with prolonged pentobarbital anaesthesia (author's transl)].
    Artru F; Guerin JM; Latarjet J; Deleuze R
    Nouv Presse Med; 1981 Apr; 10(16):1301-4. PubMed ID: 7220302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barbiturate therapy reduces nitrogen excretion in acute head injury.
    Fried RC; Dickerson RN; Guenter PA; Stein TP; Gennarelli TA; Dempsey DT; Buzby GP; Mullen JL
    J Trauma; 1989 Nov; 29(11):1558-64. PubMed ID: 2585568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral hemodynamic effects of pentobarbital coma in head-injured patients.
    Cormio M; Gopinath SP; Valadka A; Robertson CS
    J Neurotrauma; 1999 Oct; 16(10):927-36. PubMed ID: 10547101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate and excitatory amino acids measured by microdialysis are decreased by pentobarbital coma in head-injured patients.
    Goodman JC; Valadka AB; Gopinath SP; Cormio M; Robertson CS
    J Neurotrauma; 1996 Oct; 13(10):549-56. PubMed ID: 8915906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Althesin in the management of head injuries: a preliminary report.
    McIlhany M; Rapport R; Dunn R; Namazie M; Delilikan A
    Neurosurgery; 1983 Jan; 12(1):77-9. PubMed ID: 6828225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of pentobarbital plasma levels in critical care patients suffering from increased intracranial pressure.
    Heinemeyer G; Roots I; Dennhardt R
    Ther Drug Monit; 1986; 8(2):145-50. PubMed ID: 3726926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of computers on patient care and research: the pentobarbital coma experience.
    Gilkison C; Ploessl J
    J Neurosci Nurs; 1986 Aug; 18(4):196-9. PubMed ID: 2943835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury.
    Eisenberg HM; Frankowski RF; Contant CF; Marshall LF; Walker MD
    J Neurosurg; 1988 Jul; 69(1):15-23. PubMed ID: 3288723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions.
    Chapron DJ; Mumford D; Pitegoff GI
    Arch Intern Med; 1979 Mar; 139(3):363-5. PubMed ID: 426582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentobarbital coma in neurosurgical patients: nutrition considerations.
    Magnuson B; Hatton J; Zweng TN; Young B
    Nutr Clin Pract; 1994 Aug; 9(4):146-50. PubMed ID: 8078453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose preference during pentobarbital self-administration by humans.
    Pickens R; Cunningham MR; Heston LL; Eckert E; Gustafson LK
    J Pharmacol Exp Ther; 1977 Nov; 203(2):310-8. PubMed ID: 909065
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dosing frequency on the development of physical dependence and tolerance to pentobarbital.
    Okamoto M; Rao S; Walewski JL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1004-8. PubMed ID: 3746655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal treatment for barbiturate dependence.
    Teggin AF; Bewley TH
    Practitioner; 1979 Jul; 223(1333):106-7. PubMed ID: 482237
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic alterations after severe head injury. Clinical relevance.
    Boucher BA; Hanes SD
    Clin Pharmacokinet; 1998 Sep; 35(3):209-21. PubMed ID: 9784934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentobarbital Removal During Continuous Venovenous Hemofiltration: Case Report and Review of the Literature.
    Hensler DM; McConnell DP; Levasseur-Franklin KE; Greathouse KM
    J Pharm Pract; 2018 Dec; 31(6):682-686. PubMed ID: 29162023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barbiturate-augmented hypothermia for reduction of persistent intracranial hypertension.
    Shapiro HM; Wyte SR; Loeser J
    J Neurosurg; 1974 Jan; 40(1):90-100. PubMed ID: 4808489
    [No Abstract]   [Full Text] [Related]  

  • 20. CRASH (Corticosteroid Randomization after Significant Head Injury Trial): landmark and storm warning.
    Bracken MB
    Neurosurgery; 2005 Dec; 57(6):1300-2; discussion 1300-2. PubMed ID: 16331179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.